These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6121871)

  • 21. Use of amfonelic acid to discriminate between classical and atypical neuroleptics and neurotensin: an in vivo voltammetric study.
    Rivest R; Jolicoeur FB; Marsden CA
    Brain Res; 1991 Mar; 544(1):86-93. PubMed ID: 1677303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endogenous opiates regulate oxytocin but not vasopressin secretion from the neurohypophysis.
    Bicknell RJ; Leng G
    Nature; 1982 Jul; 298(5870):161-2. PubMed ID: 7088170
    [No Abstract]   [Full Text] [Related]  

  • 23. Spiperone differentiates multiple 5-hydroxytryptamine responses in rat hippocampal slices in vitro.
    Beck SG; Clarke WP; Goldfarb J
    Eur J Pharmacol; 1985 Oct; 116(1-2):195-7. PubMed ID: 2932343
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of electric foot shock on dopamine and 3,4-dihydroxyphenylacetic acid (DOPAC) in different brain areas of rats.
    Fadda F; Melis MR; Argiolas A
    Boll Soc Ital Biol Sper; 1978 Sep; 54(18):1747-50. PubMed ID: 753259
    [No Abstract]   [Full Text] [Related]  

  • 25. Choline and physostigmine enhance haloperidol-induced HVA and DOPAC accumulation.
    Millington WR; Wurtman RJ
    Eur J Pharmacol; 1982 Jun; 80(4):431-4. PubMed ID: 7106193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does brain 3,4-dihydroxyphenylacetic acid reflect dopamine release?
    Soares-da-Silva P
    J Pharm Pharmacol; 1987 Feb; 39(2):127-9. PubMed ID: 2881997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measurement of 3,4-dihydroxyphenylacetic acid and 3-methoxytyramine specific activity rat striatum.
    Di Giulio AM; Groppetti A; Algeri S; Ponzio F; Cattabeni F; Galli CL
    Anal Biochem; 1979 Jan; 92(1):82-90. PubMed ID: 426290
    [No Abstract]   [Full Text] [Related]  

  • 28. Interaction of dihydroxy-2-aminotetralin derivatives at sites labelled with [3H]clonidine, [3H]prazosin and [3H]spiperone in rat brain membranes.
    Chatterjee TK; Bhatnagar RK; Cannon JG; Long JP
    Eur J Pharmacol; 1984 Feb; 98(2):293-6. PubMed ID: 6714312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discrimination of neuroleptics by means of their interaction with amfonelic acid: an attempt to characterize the test.
    Waldmeier PC; Huber H; Heinrich M; Stoecklin K
    Biochem Pharmacol; 1985 Jan; 34(1):39-44. PubMed ID: 2857083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of drugs on regional brain concentrations of dopamine and dihydroxyphenylacetic acid.
    Umezu K; Moore KE
    J Pharmacol Exp Ther; 1979 Jan; 208(1):49-56. PubMed ID: 32385
    [No Abstract]   [Full Text] [Related]  

  • 31. Purification of neurocatin, a neuroregulatory factor from brain.
    Yee DK; Pastuszko P; Pastuszko A; Wilson DF
    Neurosci Lett; 1990 Jul; 114(2):213-9. PubMed ID: 2395532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simultaneous determination of the formation rate of dopamine and its metabolite 3,4-dihydroxyphenylacetic acid (DOPAC) in various rat brain areas.
    Westerink BH; Spaan SJ
    Brain Res; 1982 Dec; 252(2):239-45. PubMed ID: 7150951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute choline administration in rat and mouse: no effect on dopamine metabolism in brain.
    Flentge F; Postema F; Medema HM; Van den Berg CJ
    Life Sci; 1981 Jul; 29(4):331-5. PubMed ID: 7278490
    [No Abstract]   [Full Text] [Related]  

  • 34. Enzymology and subcellular localization of aldehyde oxidation in rat liver. Oxidation of 3,4-dihydroxyphenylacetaldehyde derived from dopamine to 3,4-dihydroxyphenylacetic acid.
    Tank AW; Weiner H; Thurman JA
    Biochem Pharmacol; 1981 Dec; 30(24):3265-75. PubMed ID: 7034733
    [No Abstract]   [Full Text] [Related]  

  • 35. Endurance training effects on striatal D2 dopamine receptor binding and striatal dopamine metabolite levels.
    MacRae PG; Spirduso WW; Cartee GD; Farrar RP; Wilcox RE
    Neurosci Lett; 1987 Aug; 79(1-2):138-44. PubMed ID: 2959886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevation by fenfluramine of 3,4-dihydroxyphenylacetic acid in brain and of corticosterone and prolactin in serum of fenfluramine-pretreated rats.
    Fuller RW; Snoddy HD; Clemens JA
    Pharmacol Res Commun; 1981 Mar; 13(3):275-80. PubMed ID: 7208571
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of amphetamine and amfonelic acid on the disposition of striatal newly synthesized dopamine.
    Miller HH; Shore PA
    Eur J Pharmacol; 1982 Feb; 78(1):33-44. PubMed ID: 6122585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potentiation by spiperone and other butyrophenones of fluid secretion by isolated salivary glands of ixodid ticks.
    Wong DL; Kaufman WR
    Eur J Pharmacol; 1981 Jul; 73(2-3):163-73. PubMed ID: 6273183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopamine re-uptake inhibitors show inconsistent effects on the in vivo release of dopamine as measured by intracerebral dialysis in the rat.
    Westerink BH; Damsma G; De Vries JB; Koning H
    Eur J Pharmacol; 1987 Mar; 135(2):123-8. PubMed ID: 3582491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of spiperone alone and in combination with anorectic agents on feeding parameters in the rat.
    Cooper SJ; Sweeney KF
    Neuropharmacology; 1980 Oct; 19(10):997-1003. PubMed ID: 7422077
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.